Global Cardiopulmonary Assist System(ECMO) Supply, Demand and Key Producers, 2023-2029
The global Cardiopulmonary Assist System(ECMO) market size is expected to reach $ 402.4 million by 2029, rising at a market growth of 4.2% CAGR during the forecast period (2023-2029).
ECMO is used for long-term extracorporeal respiratory and circulatory support for patients, replacing the functions of the patient's own heart and lungs, completing oxygenation of blood outside the body and expelling carbon dioxide.
This report studies the global Cardiopulmonary Assist System(ECMO) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiopulmonary Assist System(ECMO), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiopulmonary Assist System(ECMO) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiopulmonary Assist System(ECMO) total production and demand, 2018-2029, (K Units)
Global Cardiopulmonary Assist System(ECMO) total production value, 2018-2029, (USD Million)
Global Cardiopulmonary Assist System(ECMO) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cardiopulmonary Assist System(ECMO) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cardiopulmonary Assist System(ECMO) domestic production, consumption, key domestic manufacturers and share
Global Cardiopulmonary Assist System(ECMO) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cardiopulmonary Assist System(ECMO) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cardiopulmonary Assist System(ECMO) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Cardiopulmonary Assist System(ECMO) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Getinge, LivaNova, Medtronic, Terumo Cardiovascular, Fresenius and Shenzhen Hannuo Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiopulmonary Assist System(ECMO) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cardiopulmonary Assist System(ECMO) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Cardiopulmonary Assist System(ECMO) Market, Segmentation by Type
V-V-ECMO
V-A-ECM
Global Cardiopulmonary Assist System(ECMO) Market, Segmentation by Application
Aldult
Newborn
Child
Companies Profiled:
Getinge
LivaNova
Medtronic
Terumo Cardiovascular
Fresenius
Shenzhen Hannuo Medical Technology
Key Questions Answered
1. How big is the global Cardiopulmonary Assist System(ECMO) market?
2. What is the demand of the global Cardiopulmonary Assist System(ECMO) market?
3. What is the year over year growth of the global Cardiopulmonary Assist System(ECMO) market?
4. What is the production and production value of the global Cardiopulmonary Assist System(ECMO) market?
5. Who are the key producers in the global Cardiopulmonary Assist System(ECMO) market?